Physician profile
Barbara A Hrach
NPI 1164575536
$4,046.89
in general payments reported to CMS, 2019-2025
33 companies · $497 in 2025
The $497 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,049 · 2020: $118 · 2021: $491 · 2022: $450 · 2023: $816 · 2024: $627 · 2025: $497.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,940.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,939.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $929.28 | 2019-2025 | Evenity, Prolia, Prolia |
| Pfizer INC. | $383.87 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $330.44 | 2019-2025 | Xifaxan |
| Novartis Pharmaceuticals Corporation | $330.41 | 2019-2024 | |
| Lilly USA, LLC | $255.84 | 2019-2025 | Mounjaro, Zepbound |
| Novo Nordisk INC | $167.10 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Teva Pharmaceuticals USA, INC. | $151.22 | 2019 | |
| Radius Health, INC. | $113.32 | 2023-2024 | Tymlos |
| Myriad Women'S Health, INC. | $108.53 | 2023 | Myrisk |
| Astrazeneca Pharmaceuticals LP | $104.92 | 2021-2025 | Airsupra, Breztri |
| Abbvie INC. | $98.00 | 2021-2024 | |
| Sanofi Pasteur INC. | $97.90 | 2019-2023 | |
| Dexcom, INC. | $97.77 | 2020-2024 | Dexcom G6 Transmitter |
| Idorsia Pharmaceuticals US INC | $93.69 | 2022-2023 | Quviviq |
| Glaxosmithkline, LLC. | $82.56 | 2019-2023 | Shingrix, Arexvy |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $78.57 | 2024-2025 | |
| Janssen Pharmaceuticals, INC | $77.08 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $72.84 | 2019-2025 | Gardasil 9, Capvaxive, Gardasil |
| Xeris Pharmaceuticals, INC. | $59.89 | 2023 | Gvoke Hypopen |
| Alk-Abello, INC | $49.16 | 2023-2024 | Odactra, Grastek, Ragwitek |
| Therapeuticsmd, INC. | $43.48 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $42.42 | 2021 | |
| Bioventus LLC | $40.58 | 2022 | |
| Astellas Pharma US INC | $29.46 | 2024 | Veozah |
| Ucb, INC. | $28.59 | 2019 | |
| Gilead Sciences, INC. | $27.61 | 2020 | |
| Medicure Pharma INC. | $27.38 | 2023 | Zypitamag |
| Sunovion Pharmaceuticals INC. | $24.32 | 2019 | |
| Exact Sciences Corporation | $23.41 | 2025 | Cologuard Collection Kit |
| Almatica Pharma LLC | $23.04 | 2021 | |
| Melinta Therapeutics, LLC | $20.62 | 2019 | |
| Shield Therapeutics INC | $19.76 | 2024 | |
| Sanofi-Aventis U.S. LLC | $13.83 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Hrach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.